Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies.

Research and practice in thrombosis and haemostasis(2021)

Cited 3|Views3
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined